-
How does monodisperse polyethylene glycol enhance the performance of PROTAC drugs?
March 10,2026.
I. Improving Synthetic Precision and Data Reliability In the construction of a PROTAC molecule, the linker is not inert; its subtle changes directly impact the final molecule's performance. Traditiona...
View More
-
Unlocking in vivo CAR-T therapy with DSPE-PEG-MAL - A chemical bridge to the next generation of cell treatment
May 21,2026.
The revolution of in vivo CAR-T is here. After decades of impressive but logistically challenging ex vivo CAR-T, 2025 marks the turning point-Capstan’s CPTX2309 entered Phase I, and AbbVie acquired Ca...
View More
-
DPPE | Sinopeg
June 5,2026.
I. Basic Information Name: 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine CAS Number: 923-61-5 Appearance: White powder Storage Conditions: Store sealed, protected from light, below -20°C. II. Struc...
View More
-
Novo Long-Acting Growth Hormone Side Chain
August 19,2026.
The Novo long-acting growth hormone side chain is a fatty acid-modified functional side chain designed for long-acting modification strategy research. This molecule combines a fatty acid structural un...
View More
-
PDLLA | D/L-Polylactic Acid (D/L-polylactic acid) | Sinopeg Polylactic Acid Products
September 14,2026.
1. Basic Introduction (Insert structural formula image) D/L-Polylactic acid (D/L-polylactic acid, abbreviated as PDLLA) is a random copolymer composed of D-lactic acid and L-lactic acid units, belongi...
View More